UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.489

Sortiert nach

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Vaccine, 2020-07, Vol.38 (33), p.5119-5122

2020

Volltextzugriff (PDF)

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States

Human vaccines & immunotherapeutics, 2018-01, Vol.14 (8), p.2016-2024

2018

Volltextzugriff (PDF)

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.926-935

2009

Volltextzugriff (PDF)

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.936-944

2009

Volltextzugriff (PDF)

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Volltextzugriff (PDF)

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Human vaccines & immunotherapeutics, 2020-03, Vol.16 (3), p.554-561

2020

Volltextzugriff (PDF)

Oral Human Papillomavirus (HPV) Infection—Are There Implications for HPV Vaccination?

The Journal of infectious diseases, 2010-02, Vol.201 (3), p.478-478

2010

Volltextzugriff (PDF)

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.525

2015

Volltextzugriff (PDF)

A Case for Immunization of Human Papillomavirus (HPV) 6/11—Infected Pregnant Women With the Quadrivalent HPV Vaccine to Prevent Juvenile-Onset Laryngeal Papilloma

The Journal of infectious diseases, 2014-05, Vol.209 (9), p.1307-1309

Shah, Keerti V.

2014

Volltextzugriff (PDF)

Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2011-08, Vol.25 (4), p.265-269

2011

Volltextzugriff (PDF)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Infectious agents and cancer, 2023-05, Vol.18 (1), p.29-29, Article 29

2023

Volltextzugriff (PDF)

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial

Human vaccines & immunotherapeutics, 2016-12, Vol.12 (12), p.3177-3185

2016

Volltextzugriff (PDF)

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A38-A48

2022

Volltextzugriff (PDF)

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status

Journal of the International AIDS Society, 2018-06, Vol.21 (6), p.e25110-n/a

2018

Volltextzugriff (PDF)

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Vaccine, 2022-04, Vol.40 (19), p.2656-2666

2022

Volltextzugriff (PDF)

Human Papillomavirus (HPV) Type 16 and Type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-Year Follow-Up

The Journal of infectious diseases, 2009-12, Vol.200 (11), p.1789-1797

2009

Volltextzugriff (PDF)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Vaccine, 2022-03, Vol.40, p.A26-A29

2022

Volltextzugriff (PDF)

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Vaccine, 2011-06, Vol.29 (28), p.4601-4607

2011

Volltextzugriff (PDF)

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A17-A25

2022

Volltextzugriff (PDF)

Association Between Common Vaginal Infections and Cervical Non–Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women

The Journal of infectious diseases, 2021-02, Vol.223 (3), p.445-451

2021

Volltextzugriff (PDF)

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Frontiers in immunology, 2020-05, Vol.11, p.1012-1012

2020

Volltextzugriff (PDF)

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344248-2344248

2024

Volltextzugriff (PDF)

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

Cancer Immunology, Immunotherapy, 2004-07, Vol.53 (7), p.642-650

2004

Volltextzugriff (PDF)

Risk Factors for Non–Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA–Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial

The Journal of infectious diseases, 2021-08, Vol.224 (3), p.503-516

2021

Volltextzugriff (PDF)

1 – 25 von 7.489

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieVaccines

SprachePortugiesisch

PublikationsformReviews

ThemaMiddle Aged

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.526)
Mit Volltextzugriff
(5.911)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.530)
Life Sciences & Biomedicine
(6.373)
Humans
(4.335)
Human Papillomavirus
(3.229)
Female
(2.492)
Vaccines
(2.194)
Medicine, Research & Experimental
(1.711)
Research & Experimental Medicine
(1.711)
Cervical Cancer
(1.478)
Microbiology
(1.471)
Infectious Diseases
(1.422)
Vaccination
(1.367)
Immunization
(1.203)
Oncology
(1.147)
Cancer
(1.144)
Papillomavirus Infections - Prevention & Control
(1.134)
Animals
(1.122)
Infections
(1.112)
Biological And Medical Sciences
(1.025)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(1.469)
Human Vaccines & Immunotherapeutics
(643)
Infectious Agents And Cancer
(340)
The Journal Of Infectious Diseases
(326)
International Journal Of Std & Aids
(235)
The journal Of Infectious Diseases
(234)
Expert Review Of Vaccines
(217)
Plos One
(115)
Cancer Immunology, Immunotherapy
(114)
Journal For Immunotherapy Of Cancer
(113)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Oral Human Papillomavirus (HPV) Infection—Are There Implications for HPV Vaccination?

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

A Case for Immunization of Human Papillomavirus (HPV) 6/11—Infected Pregnant Women With the Quadrivalent HPV Vaccine to Prevent Juvenile-Onset Laryngeal Papilloma

Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Human Papillomavirus (HPV) Type 16 and Type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-Year Follow-Up

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Association Between Common Vaginal Infections and Cervical Non–Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

Risk Factors for Non–Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA–Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial

Aktive Filter

Suchergebnisse filtern